title: [Clinical value of OK-432 immunotherapy after one-shot arterial infusion of anti-cancer agents in the treatment of hepatocellular carcinoma--a randomized study].
authors.affiliation: 2nd Dept. of Medicine, Tottori University School of Medicine.
authors.forename: Y
authors.initials: Y
authors.lastname: Horie
authors.forename: K
authors.initials: K
authors.lastname: Hirai
authors.forename: M
authors.initials: M
authors.lastname: Shimizu
authors.forename: J
authors.initials: J
authors.lastname: Inoue
authors.forename: Y
authors.initials: Y
authors.lastname: Kubo
authors.forename: Y
authors.initials: Y
authors.lastname: Hara
authors.forename: K
authors.initials: K
authors.lastname: Tanikawa
authors.forename: M
authors.initials: M
authors.lastname: Okumura
authors.forename: C
authors.initials: C
authors.lastname: Hirayama
authors.forename: N
authors.initials: N
authors.lastname: Ogawa
mesh_terms: D000284:Administration, Oral; D001688:Biological Products / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000401:mortality / Q000628:therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D007261:Infusions, Intra-Arterial; D008113:Liver Neoplasms / Q000401:mortality / Q000628:therapy*; D016685:Mitomycin; D008937:Mitomycins / Q000008:administration & dosage*; D010844:Picibanil / Q000627:therapeutic use*; D011897:Random Allocation; D005641:Tegafur / Q000008:administration & dosage
chemical_list: D001688:Biological Products; D008937:Mitomycins; D005641:Tegafur; D010844:Picibanil; D016685:Mitomycin